-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
AstraZeneca vaccine adds potential side effects: rare blood disease after vaccination |
China News Service, June 13th.
According to a Reuters report on the 12th, the European Medicines Agency recently listed another rare blood disease, capillary leak syndrome (CLS), as a potential vaccine for AstraZeneca’s new crown vaccine.
Side effects
.
According to reports, the European Medicines Agency Security Committee will 11 be noted that AstraZeneca have such side effects listed on the label
.
Committee also recommended that, after the emergence of people but had CLS swelling and blood pressure should not be vaccinated AstraZeneca vaccine
Committee members
The European Medicines Agency began investigating these cases in April
.
Committee will review the CLS been six cases, patients are female, they vaccinated with the vaccine AstraZeneca, one of the vaccinated death; the other three had a history of CLS
Committee member
The report pointed out that the latest recommendations of the European Medicines Agency put AstraZeneca into a deeper predicament
.
Previously, many countries had reported cases of death from blood clots after inoculation with AstraZeneca vaccine, which once caused concern
According to Reuters, as of now, more than 78 million doses of AstraZeneca vaccine have been injected in European Union countries, Iceland, Norway and the United Kingdom
Focus on the new crown pneumonia epidemic